BackGenerate Biomedicines Overview

Generate Biomedicines Current Cash

Generate Biomedicines's current cash is $140M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$135.36M

Peer trimmed avg / median

Loading

Generate Biomedicines Current Cash History

Loading

Generate Biomedicines vs. peers: Current Cash Comparison

Loading

Generate Biomedicines Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Generate Biomedicines (GENB) FAQ

As of the most recent data (June 2026), GENB shows a current cash of $140M. Scroll down for historical charts and peer comparison views.

Tracking GENB's current cash over time shows whether Generate Biomedicines is scaling, shrinking, or reshaping that part of the business. The current reading is $140M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Generate Biomedicines's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $140M) with ownership activity and broader fundamentals.